[THE INVESTOR] As of Feb. 21 11:55 A.M., Medy-Tox increased 3.05%, compared with yesterday, to 429,200 won. It had increased 3.1% through the past month. Standard deviation, which indicates risk, records 2.8% over the same period over one month.
Compared with its close competitors within the same industry, KOSDAQ, the monthly earnings rate of Medy-Tox was proper and its volatility within 1 month was also at a proper rate. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 1.1. The return-on-risk is much better than the industrial mean, -0.6, and thus the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.